At Travere, we are committed to making a difference for people living with rare kidney disease.
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop, and deliver life-changing therapies to people living with rare disease.
Living with rare disease requires courage, strength, resilience, community — and, sometimes, even a little bit of humor.
We are excited to announce the full approval of our non-immunosuppressive treatment for IgA nephropathy, and are grateful to the patient community, clinical trial investigators, patient advocacy organizations and all those who worked so hard to reach this milestone. Developing this medicine could not have been possible without the passion and collaboration of the rare kidney disease community.
We are driven by science
The science we are advancing in rare kidney and metabolic disease has the potential to set new standards of care and bring hope to people with these rare disorders.